To our knowledge, this is the first systematic review comparing ART outcomesfollowing COS using the long GnRH-agonist protocol versusthe GnRH-antagonist protocol specifically for women with endometriosis inaccordance with PRISMA guidelines. Here, GNRH1 is linked to endometriosis.